BDTX · Black Diamond Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Versant Venture Capital VI, L.P. 10% Owner | ▼ Sell | Open Market | 3,726,341 Shares held | 8/28/2024 | View profile |
| RA CAPITAL MANAGEMENT, L.P. Director | ▲ Buy | Open Market | 3,213,828 Shares held | 7/5/2023 | View profile |
| Growth N. Biotech V 10% Owner | ▼ Sell | Open Market | 2,733,547 Shares held | 3/19/2025 | View profile |
| Epstein David M. SEE REMARKS | ▼ Sell | Open Market | 671,423 Shares held | 6/27/2023 | View profile |
| Elizabeth Buck CHIEF SCIENTIFIC OFFICER | ▲ Buy | Grant | 170,192 Shares held | 1/30/2025 | View profile |
| Ni Fang SEE REMARKS | ▲ Buy | Open Market | 125,389 Shares held | 12/22/2022 | View profile |
| Mark A. Velleca PRESIDENT & CEO | ▲ Buy | Grant | 121,522 Shares held | 1/30/2025 | View profile |
| Ali Behbahani Director | ▲ Buy | Grant | 110,236 Shares held | 9/18/2026 | View profile |
| Erika Jones SEE REMARKS | ▲ Buy | Grant | 85,150 Shares held | 1/30/2025 | View profile |
| Brent Hatzis-Schoch SEE REMARKS | ▲ Buy | Grant | 83,400 Shares held | 1/30/2025 | View profile |
| Sergey Yurasov CHIEF MEDICAL OFFICER | ▲ Buy | Grant | 75,000 Shares held | 1/30/2025 | View profile |
| Prakash Raman | ▲ Buy | Grant | 51,840 Shares held | 9/18/2026 | View profile |
| INGRAM ROBERT ALEXANDER Director | ▲ Buy | Grant | 42,854 Shares held | 12/16/2022 | View profile |
| DIXON WENDY L Director | ▲ Buy | Grant | 38,054 Shares held | 3/15/2024 | View profile |
| Shannon Campbell Director | ▲ Buy | Grant | 8,865 Shares held | 12/13/2024 | View profile |
Transaction History
| Ali Behbahani | ▲ Buy | Grant | 7,707 | $15K | 9/18/2026 |
| Prakash Raman | ▲ Buy | Grant | 6,801 | $13K | 9/18/2026 |
| Ali Behbahani | ▲ Buy | Grant | 8,961 | $15K | 6/19/2026 |
| Prakash Raman | ▲ Buy | Grant | 7,907 | $13K | 6/19/2026 |
| Ali Behbahani | ▲ Buy | Grant | 6,919 | $15K | 3/20/2026 |
| Prakash Raman | ▲ Buy | Grant | 6,105 | $13K | 3/20/2026 |
| Ali Behbahani | ▲ Buy | Grant | 5,208 | $14K | 12/12/2025 |
| Prakash Raman | ▲ Buy | Grant | 4,665 | $13K | 12/12/2025 |
| Ali Behbahani | ▲ Buy | Grant | 4,291 | $14K | 9/19/2025 |
| Prakash Raman | ▲ Buy | Grant | 3,843 | $13K | 9/19/2025 |
| Ali Behbahani | ▲ Buy | Grant | 6,170 | $14K | 6/20/2025 |
| Prakash Raman | ▲ Buy | Grant | 5,526 | $13K | 6/20/2025 |
| Ali Behbahani | ▲ Buy | Grant | 7,646 | $14K | 3/21/2025 |
| Prakash Raman | ▲ Buy | Grant | 6,848 | $13K | 3/21/2025 |
| Growth N. Biotech V | ▼ Sell | Open Market | 1,000,000 | $2.1M | 3/19/2025 |
| Growth N. Biotech V | ▼ Sell | Open Market | 300,000 | $583K | 3/19/2025 |
| Growth N. Biotech V | ▼ Sell | Open Market | 1,000,000 | $2.3M | 3/19/2025 |
| Growth N. Biotech V | ▼ Sell | Open Market | 2,000,000 | $4.0M | 3/19/2025 |
| Growth N. Biotech V | ▼ Sell | Open Market | 400,000 | $837K | 3/19/2025 |
| Growth N. Biotech V | ▼ Sell | Open Market | 584,292 | $1.1M | 3/19/2025 |
| Growth N. Biotech V | ▼ Sell | Open Market | 500,000 | $1.1M | 3/19/2025 |
| Mark A. Velleca | ▲ Buy | Grant | 75,000 | $0 | 1/30/2025 |
| Sergey Yurasov | ▲ Buy | Grant | 75,000 | $0 | 1/30/2025 |
| Elizabeth Buck | ▲ Buy | Grant | 75,000 | $0 | 1/30/2025 |
| Erika Jones | ▲ Buy | Grant | 75,000 | $0 | 1/30/2025 |
| Brent Hatzis-Schoch | ▲ Buy | Grant | 75,000 | $0 | 1/30/2025 |
| Prakash Raman | ▲ Buy | Grant | 5,150 | $13K | 12/13/2024 |
| Shannon Campbell | ▲ Buy | Grant | 4,500 | $11K | 12/13/2024 |
| Ali Behbahani | ▲ Buy | Grant | 5,750 | $14K | 12/13/2024 |
| Ali Behbahani | ▲ Buy | Grant | 3,007 | $14K | 9/20/2024 |
| Shannon Campbell | ▲ Buy | Grant | 2,354 | $11K | 9/20/2024 |
| Prakash Raman | ▲ Buy | Grant | 2,694 | $13K | 9/20/2024 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 221,600 | $1.4M | 8/28/2024 |
| Ali Behbahani | ▲ Buy | Grant | 2,887 | $14K | 6/21/2024 |
| Prakash Raman | ▲ Buy | Grant | 2,301 | $11K | 6/21/2024 |
| Shannon Campbell | ▲ Buy | Grant | 2,011 | $10K | 6/21/2024 |
| Ali Behbahani | ▲ Buy | Grant | 3,166 | $14K | 3/15/2024 |
| DIXON WENDY L | ▲ Buy | Grant | 3,253 | $15K | 3/15/2024 |
| Ali Behbahani | ▲ Buy | Grant | 4,455 | $12K | 12/15/2023 |
| DIXON WENDY L | ▲ Buy | Grant | 4,043 | $11K | 12/15/2023 |
| Growth N. Biotech V | ▲ Buy | Open Market | 400,000 | $934K | 10/17/2023 |
| Ali Behbahani | ▲ Buy | Grant | 3,299 | $12K | 9/15/2023 |
| Mark A. Velleca | ▲ Buy | Grant | 5,208 | $19K | 9/15/2023 |
| DIXON WENDY L | ▲ Buy | Grant | 2,986 | $11K | 9/15/2023 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 935,850 | $4.7M | 7/5/2023 |
| Ali Behbahani | ▲ Buy | Open Market | 1,000,000 | $5.0M | 7/5/2023 |
| Growth N. Biotech V | ▲ Buy | Open Market | 1,000,000 | $5.0M | 6/30/2023 |
| Growth N. Biotech V | ▲ Buy | Open Market | 1,740,000 | $9.6M | 6/27/2023 |
| Epstein David M. | ▼ Sell | Open Market | 25,000 | $168K | 6/27/2023 |
| Ali Behbahani | ▲ Buy | Grant | 5,655 | $12K | 6/16/2023 |
| DIXON WENDY L | ▲ Buy | Grant | 5,119 | $11K | 6/16/2023 |
| Mark A. Velleca | ▲ Buy | Grant | 8,929 | $19K | 6/16/2023 |
| Ali Behbahani | ▲ Buy | Grant | 7,111 | $12K | 3/16/2023 |
| DIXON WENDY L | ▲ Buy | Grant | 6,437 | $11K | 3/16/2023 |
| Mark A. Velleca | ▲ Buy | Grant | 11,228 | $19K | 3/16/2023 |
| Erika Jones | ▲ Buy | Grant | 5,075 | $0 | 2/13/2023 |
| Ni Fang | ▲ Buy | Open Market | 36,363 | $47K | 12/22/2022 |
| Ni Fang | ▲ Buy | Open Market | 20,000 | $26K | 12/21/2022 |
| Ali Behbahani | ▲ Buy | Grant | 7,917 | $12K | 12/16/2022 |
| Mark A. Velleca | ▲ Buy | Grant | 8,424 | $13K | 12/16/2022 |
| DIXON WENDY L | ▲ Buy | Grant | 7,167 | $11K | 12/16/2022 |
| INGRAM ROBERT ALEXANDER | ▲ Buy | Grant | 9,375 | $14K | 12/16/2022 |
| Growth N. Biotech V | ▲ Buy | Open Market | 99,801 | $225K | 10/31/2022 |
| Growth N. Biotech V | ▲ Buy | Open Market | 172,974 | $377K | 10/28/2022 |
| Growth N. Biotech V | ▲ Buy | Open Market | 191,678 | $359K | 10/27/2022 |
| Growth N. Biotech V | ▲ Buy | Open Market | 87,850 | $133K | 10/21/2022 |
| Growth N. Biotech V | ▲ Buy | Open Market | 53,734 | $76K | 10/20/2022 |
| Growth N. Biotech V | ▲ Buy | Open Market | 77,689 | $103K | 10/19/2022 |
| Ali Behbahani | ▲ Buy | Grant | 4,532 | $12K | 9/16/2022 |
| DIXON WENDY L | ▲ Buy | Grant | 4,103 | $11K | 9/16/2022 |
| Mark A. Velleca | ▲ Buy | Grant | 4,294 | $11K | 9/16/2022 |
| INGRAM ROBERT ALEXANDER | ▲ Buy | Grant | 6,584 | $17K | 9/16/2022 |
| Ni Fang | ▲ Buy | Open Market | 25,000 | $61K | 6/29/2022 |
| Ali Behbahani | ▲ Buy | Grant | 5,850 | $12K | 6/17/2022 |
| Mark A. Velleca | ▲ Buy | Grant | 5,542 | $11K | 6/17/2022 |
| DIXON WENDY L | ▲ Buy | Grant | 4,060 | $8K | 6/17/2022 |
| INGRAM ROBERT ALEXANDER | ▲ Buy | Grant | 8,498 | $17K | 6/17/2022 |
| Growth N. Biotech V | ▲ Buy | Open Market | 255,711 | $658K | 4/28/2022 |
| Growth N. Biotech V | ▲ Buy | Open Market | 150,000 | $399K | 4/27/2022 |
| Growth N. Biotech V | ▲ Buy | Open Market | 150,000 | $487K | 4/19/2022 |
| Growth N. Biotech V | ▲ Buy | Open Market | 150,000 | $494K | 4/18/2022 |
| Growth N. Biotech V | ▲ Buy | Open Market | 102,556 | $366K | 4/13/2022 |
| Growth N. Biotech V | ▲ Buy | Open Market | 150,000 | $514K | 4/12/2022 |
| Ali Behbahani | ▲ Buy | Grant | 4,346 | $13K | 3/18/2022 |
| INGRAM ROBERT ALEXANDER | ▲ Buy | Grant | 5,795 | $18K | 3/18/2022 |
| Mark A. Velleca | ▲ Buy | Grant | 2,897 | $9K | 3/18/2022 |
| Erika Jones | ▲ Buy | Grant | 5,075 | $0 | 2/15/2022 |
| Ali Behbahani | ▲ Buy | Grant | 2,472 | $13K | 12/17/2021 |
| INGRAM ROBERT ALEXANDER | ▲ Buy | Grant | 3,296 | $18K | 12/17/2021 |
| Ali Behbahani | ▲ Buy | Grant | 1,326 | $13K | 9/17/2021 |
| INGRAM ROBERT ALEXANDER | ▲ Buy | Grant | 1,869 | $19K | 9/17/2021 |